Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026
Q2 2026
Est. EPS: $13.46
Actual EPS: $14.29
EPS surprise: 40.69%
Company overview
Market Cap$76.2B
PriceUSD 727.02
P/E17.71
EPS (TTM)41.04
52-week high821.11
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410